Pages

Tuesday, May 5, 2015

Swiss stocks - Factors to watch on May 5

<span id="midArticle_start"/> May 5 (Reuters) - The Swiss blue-chip SMI was seen opening 0.2 percent lower at 9,079 points, according topremarket indications by bank Julius Baer.

<span id="midArticle_0"/>The following are some of the main factors expected toaffect Swiss stocks on Tuesday:

<span id="midArticle_1"/>
<span id="midArticle_2"/>CREDIT SUISSE

<span id="midArticle_3"/>Credit Suisse has quietly withdrawn a request fora waiver to raise capital more easily, after U.S. Securities andExchange Commission staffers told the bank in recent weeks itwould not win approval, people familiar with the matter toldReuters.

<span id="midArticle_4"/>For more, click on

<span id="midArticle_5"/>
<span id="midArticle_6"/>UBS

<span id="midArticle_7"/>UBS said it is in advanced talks with the U.S.Department of Justice to settle allegations of foreign exchangemarket rigging, as Switzerland's biggest bank postedforecast-beating first-quarter earnings.

<span id="midArticle_8"/>For more, click on

<span id="midArticle_9"/>
<span id="midArticle_10"/>HOLCIM

<span id="midArticle_11"/>Holcim Ltd, a Swiss cement maker, and Lafarge S.A., which is based in Paris, on Monday won U.S. antitrustapproval to merge after they agreed to divest assets, theFederal Trade Commission.

<span id="midArticle_12"/>For more, click on

<span id="midArticle_13"/>
<span id="midArticle_14"/>SIKA

<span id="midArticle_15"/>The Swiss financial regulator on Monday denied an appeal byinvestors including Bill Gates over a proposed 2.75 billionSwiss franc ($3 billion) takeover of Swiss firm Sika byFrench rival Saint-Gobain.

<span id="midArticle_0"/>For more, click on

<span id="midArticle_1"/>
<span id="midArticle_2"/>COMPANY STATEMENTS

<span id="midArticle_3"/>* Dufry said it swung to a first-quarter net lossof 9 million francs after amortization from the acquisition ofNuance. The duty-free retailer said the integration is expectedto be completed by year-end and confirmed the 70 million francsin synergies it expects to reap in 2016, but said smallcontributions could already by seen in 2015.

<span id="midArticle_4"/>* Swisslog said first-quarter earnings beforeinterest and tax rose sharply to 3.3 million francs as thecompany worked down a large order backlog from year-end,publishing quarterly figures for the first time in order toalign its reporting practices with those of KUKA AG, its mainshareholder.

<span id="midArticle_5"/>* Basilea said a clinical phase 1 study with theorally administered investigational drug BAL3833/CCT3833 inpatients with advanced solid tumors began. BAL3833/CCT3833 isthe lead compound of a series of small molecule panRAFinhibitors recently in-licensed by Basilea.

<span id="midArticle_6"/>* Helvetia said the takeover of Nationale Suissesuccessfully completed and the two firms' insurance units havebeen merged. At the same time, an integrated organisation modelhas been introduced for office and field staff.

<span id="midArticle_7"/>
<span id="midArticle_8"/>ECONOMY

<span id="midArticle_9"/>(Reporting by Zurich newsroom)

<span id="midArticle_10"/>


via Smart Health Shop Forum http://ift.tt/1Pktm2W

No comments:

Post a Comment